Anil Vaidya is a fractional CEO and Chief Strategy Officer with over 20 years’ experience in life sciences, spanning medical devices, diagnostics, digital health, pharmaceuticals, and biotechnology. He advises companies, investors, and governments on investment strategy, foreign direct investment, and international market entry.

Anil has launched and scaled businesses across the UK and Asia, built cross-border teams, and led initiatives bridging public and private sectors. His expertise lies in growth strategy, commercial due diligence, and positioning regions as global hubs for innovation.